Published in
SpringerOpen, Clinical and Translational Medicine, 6(12), 2022
DOI: 10.1002/ctm2.883
Links
Tools
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.
Journal article published in 2022 by
Anna Reustle,
Lena‐Sophie Menig,
Patrick Leuthold,
Ute Hofmann,
Viktoria Stühler,
Christian Schmees 
,
Mathias Haag,
Verena Klumpp,
Stefan Winter,
Steffen Rausch,
Jörg Hennenlotter,
Falko Fend,
Marcus Scharpf,
Arnulf Stenzl,
Matthias Schwab
and other authors.
,
Mathias Haag,
Verena Klumpp,
Stefan Winter,
Steffen Rausch,
Jörg Hennenlotter,
Falko Fend,
Marcus Scharpf,
Arnulf Stenzl,
Matthias Schwab
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 